Case Report
Zinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease?
Table 1
Laboratory result at presentation and on follow-up.
| Laboratory parameters | At presentation | Subsequent laboratory measurement on follow-up | 2nd week | 3rd week | 5th week | 7th week |
| WBC (4.0–10.5 × 103/L) | 8.4 | | | | | Hemoglobin (12.5–16.1) | 12 | | | | | Platelet (150–4500 × 103) | 247 | | | | | AST (5–45 IU/L) | 130 | 97 | 59 | 30 | 37 | ALT (5–45 IU/L) | 58I | 160 | 60 | 24 | 30 | ALP (115 IU/L) | 300 | | | | | Serum albumin (3.2–5.1 gm/L) | 1.7 | 2.7 | 2.2 | 3.9 | 4 | Total protein | | 9.3 | 8.4 | 8.5 | 8.7 | PT (11–14 sec) | 28.8 | 32.4 | 32 | 18.1 | 12 | APTT (25–35 sec) | 38.5 | 36.8 | 35 | 34.2 | 30 | INR (0.8–1.2) | 2.62 | 2.88 | 2.8 | 1.62 | 1.3 | Total bilirubin (mg/dl) | 5 | 5.3 | 3.2 | 0.8 | 1 | Serum ceruloplasmin (20–60 mg/dl) | <8 | | | | | 24 hr urine copper (mcg/dl) | 150 | | | | | Slit lamp examination | Kayser-Fleischer rings |
|
|